Furthermore, during the search for BRCA1/2-associated factors, the current study identified RBBP8 (CtIP), whose expression level was reduced specifically in BRCA2 mutation-associated HRD tumors. This evidence concerns the gene RBBP8 and hypoparathyroidism-retardation-dysmorphism syndrome.